USC Norris Comprehensive Cancer Center
USC Norris
>
Clinical Trials
About USC Norris
Research
Patient Care
Search Trials
FAQ - Trials
Contact Us - Trials
IRB
Membership
Education
Shared Resources
Support USC Norris
» Contact Us
» Glossary
» Make a Donation
If you are a patient, please contact
The Doctors of USC
at 800-USC-CARE.
Details for trial 16M-08-1
Description:
A Phase I/II, Multi-Center, Open-Label, Dose-Escalation Study of Elotuzumab (Humanized anti-CS1 Monoclonal IgG1 antibody, formerly HuLuc63) and Bortezomib in Subjects with Multiple Myeloma Following One to Three Prior Therapies.
Status:
Closed
Randomized?
No
Researchers
Principal Investigator
Title
Ann Mohrbacher
M.D.
Data Management
Name
Title
Lori Vergara
R.N.
Yvonne Avila
D.M.
Rebecca Amezcua
R.N.
You may participate in this study if:
(No criteria found)
You may not participate in this study if:
(No criteria found)
For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.
